Gastroenterology Endogastro Rio Clinic, 43/1101, Siqueira Campos Street, Rio de Janeiro, RJ, 22031-901, Brazil.
Post Graduation Program in Clinical and Experimental Pathophysiology, Rio de Janeiro State University, Rio de Janeiro, Brazil.
Obes Surg. 2019 Mar;29(3):843-850. doi: 10.1007/s11695-018-3609-x.
Obesity is an important risk factor for several chronic diseases and also is associated with worse quality of life. Intragastric balloon (IGB) is an effective method for weight loss. Although changes in lifestyle are critical to weight loss during and after IGB therapy, only a few studies evaluated dietary intake and none evaluated changes in physical activity with a validated questionnaire during the treatment. The aim of this study was to evaluate changes in total and central body adiposity, dietary intake, physical activity, and quality of life of patients with obesity submitted to IGB treatment for 6 months.
Prospective observational study involving 42 patients with obesity using IGB for 6 months. The patients were evaluated, on the day of insertion and withdrawal or adjustment of IGB for total and central body adiposity (anthropometry and bioelectrical impedance), dietary intake, physical activity (Baecke questionnaire), and quality of life (SF-36 questionnaire).
There was a significant decrease in total and central body adiposity. The mean % total weight loss and % excess weight loss were 15.88 ± 1.42 and 56.04 ± 4.90, respectively and waist circumference decreased 13.33 ± 1.39 cm. There was a reduction in energy intake, an increase in physical activity, and an improvement of quality of life during IGB treatment.
The present study suggests that IGB treatment during 6 months in individuals with obesity is effective for decreasing total and central body adiposity being associated with reduction in energy intake, increase in physical activity, and improvement in quality of life.
肥胖是多种慢性疾病的重要危险因素,同时也与生活质量的下降有关。胃内球囊(IGB)是一种有效的减肥方法。尽管在 IGB 治疗期间和之后改变生活方式对于减肥至关重要,但只有少数研究评估了饮食摄入,并且没有使用经过验证的问卷评估治疗期间身体活动的变化。本研究旨在评估肥胖患者接受 IGB 治疗 6 个月后总身体和中心身体脂肪、饮食摄入、身体活动和生活质量的变化。
前瞻性观察研究涉及 42 名肥胖患者,使用 IGB 治疗 6 个月。患者在插入和取出或调整 IGB 时进行评估,以评估总身体和中心身体脂肪(人体测量学和生物电阻抗)、饮食摄入、身体活动(Baecke 问卷)和生活质量(SF-36 问卷)。
总身体和中心身体脂肪均显著下降。总体重减轻的平均百分比和多余体重减轻的平均百分比分别为 15.88±1.42 和 56.04±4.90,腰围减少了 13.33±1.39 厘米。IGB 治疗期间能量摄入减少,身体活动增加,生活质量改善。
本研究表明,肥胖患者接受 6 个月的 IGB 治疗可有效降低总身体和中心身体脂肪,同时与能量摄入减少、身体活动增加和生活质量改善相关。